Formidable Asset Management Boosts Key Stakes, Adjusts Portfolio Across Multiple Equities in Q1

BCAT saw broader institutional activity in Q1 beyond Formidable, with Cohen & Steers increasing to 1,632,657 shares ($23,118,000), Bank of America adding 116,151 shares to 1,424,014 ($21,560,000), Rivernorth Capital Management establishing a new position worth about $19,940,000, Invesco elevating to 1,324,286 shares ($19,586,000) after buying 54,297, and Raymond James Financial Inc. raising its stake by 93,659 to 467,447 shares ($6,914,000). Overall institutional ownership is 36.12% of BCAT.
For Royalty Pharma (RPRX), aside from Formidable’s 21.1% reduction to 43,969 shares ($2.109M), other investors increased exposure: Pictet Asset Management Holding SA rose 12.4% to 352,428 shares ($16.664M); Barton Investment Management opened a new stake ($905,000); Kestra Private Wealth Services opened a new stake ($244,000); Blue Trust Inc. expanded 173.4% to 689 shares ($33,000); Banque Cantonale Vaudoise opened a new position ($102,000); director Gregory Norden sold 3,045 shares on May 14, leaving 191,803 shares ($10.166M). Institutional ownership stands at 54.35%.
In Talen Energy (TLN), beyond Formidable’s 38.6% increase to 4,641 shares ($1.482M), notable new or expanded positions include Amundi opening a new stake (~$299,000), AQR Capital Management opening a new stake (~$1.732M), MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increasing by 11.7% to 7,280 shares ($1.454M), NewEdge Advisors LLC boosting to 875 shares (~$175,000) after buying 870, and UBS AM A Distinct BU increasing to 49,050 shares ($9.794M) after adding 6,498. Hedge funds and other institutional investors collectively own about 0.38% of TLN.
In abrdn Life Sciences Investors (HQL), Formidable’s stake rose 27.3% to 158,385 shares ($2.658M). Other big moves include Royal Bank of Canada increasing its stake by 53.3% to 73,475 shares ($934,000), NewEdge Advisors adding 32,500 shares ($412,000), First Trust Advisors LP boosting 112.2% to 35,321 shares ($452,000), Raymond James Financial Inc. increasing 20.3% to 375,960 shares ($4.816M), and Clough Capital Partners L P initiating a new stake. Institutional ownership sits at 32.21%.
Formidable Asset Management LLC added 65,921 shares of BlackRock Capital Allocation Term Trust (BCAT) in the first quarter of 2026, bringing the value of its new stake to roughly $933,000, according to Watchlist News. The Cincinnati-based firm, which managed about $902.3 million in assets at quarter's end, also boosted its Talen Energy (TLN) holding by 38.6% and its abrdn Life Sciences Investors (HQL) stake by 27.3%, while trimming its Royalty Pharma (RPRX) position by 21.1%.
The moves, disclosed in mandatory 13F filings with the SEC by the May 14 deadline, reflect a broader institutional rotation into income-generating closed-end funds and nuclear-adjacent energy plays during a volatile first quarter.
Formidable's BCAT purchase gives it roughly 0.06% of the fund. BCAT is a BlackRock closed-end fund that blends equity, debt, and option-writing strategies to generate income. The firm also pushed its HQL stake to 158,385 shares, worth about $2.66 million. HQL, the abrdn Life Sciences fund, trades at an 11.82% discount to its net asset value (NAV) of $21.35 and pays an 11.77% distribution rate, according to CEF Connect.
On the energy side, Formidable raised its Talen Energy position to 4,641 shares, valued at about $1.48 million. Talen operates a 2.5 GW nuclear facility in Pennsylvania and co-locates data centers on-site to sell carbon-free power directly to cloud customers. The firm's CEO Mac McFarland has called this
On the energy side, Formidable raised its Talen Energy position to 4,641 shares, valued at about $1.48 million. Talen operates a 2.5 GW nuclear facility in Pennsylvania and co-locates data centers on-site, selling carbon-free power to cloud clients including Amazon Web Services. Talen reported $473 million in Adjusted EBITDA for Q1 2026, per GlobeNewswire.
Formidable sold 11,768 shares of Royalty Pharma, reducing its stake by 21.1% to 43,969 shares worth about $2.11 million. The sale runs counter to moves by several other institutions. Pictet Asset Management grew its RPRX position by 12.4% to 352,428 shares ($16.6 million). Barton Investment Management and Kestra Private Wealth Services both opened new positions in the stock during the same period.
Analysts at Barchart have flagged concern over RPRX's long-term revenue growth, which has averaged roughly 2.1% annually. Royalty Pharma internalized its management in May 2025 and reported double-digit growth in royalty receipts for Q1 2026, according to GlobeNewswire. Overall institutional ownership in RPRX stands at 54.35%. Director Gregory Norden sold 3,045 shares on May 14 under a pre-arranged trading plan, leaving him with 191,803 shares worth about $10.2 million.
Formidable was far from alone in buying BCAT during Q1. Cohen & Steers held 1,632,657 shares worth $23.1 million, the largest disclosed position. Bank of America added 116,151 shares to reach 1,424,014 shares ($21.5 million). Rivernorth Capital Management opened a brand-new stake worth about $19.9 million. Invesco also added 54,297 shares to reach 1,324,286 shares ($19.6 million), per Watchlist News.
Raymond James Financial raised its BCAT stake by 93,659 shares to 467,447 shares, valued at $6.9 million. Overall institutional ownership in BCAT now sits at 36.12%. The flood of institutional buying suggests broad confidence that BCAT's mix of bonds, stocks, and covered calls is well-suited to a choppy interest rate environment in 2026.
Talen Energy attracted several new institutional buyers in Q1. AQR Capital Management opened a new stake worth about $1.73 million. UBS added 6,498 shares to reach 49,050 shares ($9.8 million). MIRAE Asset Global ETFs raised its TLN holding by 11.7% to 7,280 shares ($1.45 million). Talen completed its acquisition of Western PJM generation assets — Waterford, Lawrenceburg, and Darby — on June 15, 2026, per GlobeNewswire.
In HQL, Royal Bank of Canada grew its stake by 53.3% to 73,475 shares ($934,000). First Trust Advisors more than doubled its position, up 112.2% to 35,321 shares ($452,000). Raymond James lifted its HQL stake 20.3% to 375,960 shares ($4.8 million). Clough Capital Partners also opened a new position. Institutional ownership in HQL stands at 32.21%, according to Watchlist News.
Publishers
12
Articles
4
Reach
16